CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-13 | Herzich Paul Chief Technology Officer | Option exercise · Restricted Stock Units 10b5-1 | −7,187 | 21,563 | ||
| 2025-02-13 | Cumbo Alexander President and CEO | Option exercise 10b5-1 | +30,031 | 72,082 | ||
| 2025-02-13 | Cumbo Alexander President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −30,031 | 90,094 | ||
| 2025-02-13 | Ganot Ilan Director | Option exercise 10b5-1 | +4,861 | 16,550 | ||
| 2025-02-13 | Ganot Ilan Director | Option exercise · Restricted Stock Units 10b5-1 | −4,861 | 14,583 | ||
| 2025-02-13 | Howton David T Chief Operating Officer | Option exercise 10b5-1 | +14,687 | 30,350 | ||
| 2025-02-13 | Howton David T Chief Operating Officer | Option exercise · Restricted Stock Units 10b5-1 | −14,687 | 44,063 | ||
| 2025-01-31 | Hanrahan Jessie Chief Regulatory Officer | Grant or award · Restricted Stock Units | +110,500 | 110,500 | ||
| 2025-01-31 | Herzich Paul Chief Technology Officer | Grant or award · Restricted Stock Units | +98,700 | 98,700 | ||
| 2025-01-31 | Ganot Ilan Director | Grant or award · Restricted Stock Units | +60,000 | 60,000 | ||
| 2025-01-31 | Tan Kevin CFO & Treasurer | Grant or award · Restricted Stock Units | +132,300 | 132,300 | ||
| 2025-01-31 | Brooks Gabriel Chief Medical Officer | Grant or award · Restricted Stock Units | +112,900 | 112,900 | ||
| 2025-01-31 | Howton David T Chief Operating Officer | Grant or award · Restricted Stock Units | +169,100 | 169,100 | ||
| 2025-01-31 | Cumbo Alexander President and CEO | Grant or award · Restricted Stock Units | +401,600 | 401,600 | ||
| 2025-01-28 | Ganot Ilan Director | Sale 10b5-1 | −144 | $3.11 | $448 | 11,689 |
| 2025-01-27 | Ganot Ilan Director | Option exercise 10b5-1 | +388 | 11,833 | ||
| 2025-01-27 | Ganot Ilan Director | Option exercise 10b5-1 | +3,883 | 98,690 | ||
| 2025-01-27 | Ganot Ilan Director | Option exercise · Restricted Stock Units 10b5-1 | −388 | 389 | ||
| 2025-01-27 | Ganot Ilan Director | Option exercise · Restricted Stock Units 10b5-1 | −3,883 | 3,884 | ||
| 2025-01-10 | Tan Kevin CFO & Treasurer | Sale | −4,073 | $3.89 | $16K | 24,789 |
Page 10 of 12 · 223 trades